136 / 1851
Neoadjuvant therapy
We advice neoadjuvant therapy in:
•
Locally advanced breast cancer
•
Breast cancer with predictive factors of response
to neoadjuvant chemotherapy or targeted
therapy (triple negative or HER2 positive BC)
13